Pages that link to "Q45412434"

The following pages link to Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients (Q45412434):

Displaying 23 items.

• Detection of HBV Covalently Closed Circular DNA (Q32183310) (← links)
• Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy (Q33918392) (← links)
• Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. (Q34080966) (← links)
• Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B (Q35043948) (← links)
• Detection of hepatitis B virus infection: A systematic review (Q36162866) (← links)
• α-Mannosidase I Protein Expression in Peripheral Blood Mononuclear Cells Is Upregulated During Hepatitis B Virus Infection (Q36475926) (← links)
• Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients (Q37212966) (← links)
• Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes (Q37417340) (← links)
• A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system (Q38851736) (← links)
• Hepatitis B "e" antigen-mediated inhibition of HBV replication fitness and transcription efficiency in vitro (Q38859190) (← links)
• A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures (Q39131353) (← links)
• DNA double-strand breaks, potential targets for HBV integration (Q39691764) (← links)
• Development of magnetic capture hybridization and quantitative polymerase chain reaction for hepatitis B virus covalently closed circular DNA. (Q41449217) (← links)
• Viral hepatitis in solid organ transplantation (Q42272319) (← links)
• Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents (Q42752863) (← links)
• The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis (Q42939279) (← links)
• Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients (Q43659537) (← links)
• Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation (Q45352477) (← links)
• Validation of a Sensitive and Specific Real-Time PCR for Detection and Quantitation of Hepatitis B Virus Covalently Closed Circular DNA in Plasma of Chronic Hepatitis B Patients (Q45356272) (← links)
• Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents (Q45370648) (← links)
• Enhanced specificity of real-time PCR for measurement of hepatitis B virus cccDNA using restriction endonuclease and plasmid-safe ATP-dependent DNase and selective primers (Q45373891) (← links)
• Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR (Q54360400) (← links)
• Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis (Q90706011) (← links)